Stay updated on Maintenance Chemotherapy for Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Maintenance Chemotherapy for Stage IV NSCLC Clinical Trial page.

Latest updates to the Maintenance Chemotherapy for Stage IV NSCLC Clinical Trial page
- CheckyesterdayChange DetectedAn NIH notice appears above the study record, announcing that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check8 days agoChange DetectedThe site footer revision advances from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now displays a 403 Forbidden error with minimal navigation, and the detailed study content and documents appear inaccessible, meaning the study record is no longer viewable on this URL.SummaryDifference17%

- Check43 days agoChange DetectedAdded Tel Litwinsky, Israel (52621) as a recruitment site and removed Qiryat Krinitzi, Israel (52621) from the study locations. This updates the geographic reach and contact points for enrolling participants in Israel.SummaryDifference0.0%

- Check50 days agoChange DetectedTel Litwinsky, Israel, 52621 was removed and Qiryat Krinitzi, Israel, 52621 was added to the Israel site list. This reflects an update to the participating sites for potential enrollment.SummaryDifference0.0%

Stay in the know with updates to Maintenance Chemotherapy for Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Maintenance Chemotherapy for Stage IV NSCLC Clinical Trial page.